Skip to main content
. Author manuscript; available in PMC: 2022 Sep 5.
Published in final edited form as: Lancet Glob Health. 2020 Jan 1;8(1):e92–e100. doi: 10.1016/S2214-109X(19)30453-X

Table 3. Risk of bias assessment of Ndyomugyenyi et al (2008)36 using the Cochrane risk-of-bias tool for randomised controlled trials.

Risk of bias Support for judgment
Random sequence generation and allocation concealment (selection bias) Unclear A random sequence was generated in SPSS; the allocation concealment method was not described
Blinding of participants and personnel (performance bias) High The study design was an open-label randomised controlled trial
Blinding of outcome assessment (detection bias) Low Severe adverse events are an objective outcome and their detection is unlikely to have been affected by no blinding
Incomplete outcome data (attrition bias) Low Loss to follow-up was similar across the different study groups, ranging from 26% to 33%
Selective outcome reporting (reporting bias) Unclear A study protocol was not found in any of the clinical trial registries; the study was not registered in any clinical trial repository
Other bias Low The authors took measures to prevent baseline imbalances between study groups